Clearview AI, Inc., Consumer Privacy

This docket consolidated claims that Clearview AI unlawfully collected and used facial-recognition data scraped from publicly available images without consent, implicating biometric-privacy statutes in several states, most prominently Illinois's Biometric Information Privacy Act. Centralized in the Northern District of Illinois in December 2020, the docket shows zero actions currently pending against fourteen total actions ever filed as of the JPML's September 2026 report — a docket that has fully wound down from an already modest filing population.

For a funder, a docket at zero pending actions offers no current portfolio-finance opportunity; whatever claim population existed has resolved, likely through the settlement mechanisms and injunctive-relief frameworks that have characterized much of the broader Clearview AI litigation across state and federal courts, only a portion of which was ever centralized in this specific MDL. Any interest in a related biometric-privacy claim today would need to be evaluated as a new or separate matter rather than as part of this now-inactive docket.

This is a data-privacy matter with no medical-lien component. Where this docket retains value is as a reference point for biometric-privacy litigation generally: a modest federal filing population here resolved relatively quickly relative to some other technology-privacy MDLs, which is useful context when evaluating the pace of biometric or facial-recognition privacy claims elsewhere. Criterica Capital's commercial litigation finance line is not presently applicable to this specific docket given its inactive status, and a structural brief on its resolution history is available through Criterica Intelligence.

Pre-settlement funding is a non-recourse purchase of a portion of the proceeds of a pending legal claim — not a loan. If the case does not result in a recovery, nothing is owed. Rates, fees, and repayment terms are disclosed in full in the funding agreement, which the applicant’s attorney reviews before signing. Availability and terms vary by state.